Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - propylthiouracilum - comprimés - propylthiouracilum 50 mg, lactosum monohydricum 73.9 mg, maydis pour amylum, de la silice colloidalis anhydrica, povidonum k 30, pour amylum pregelificatum, magnésium stearas, pro compresso. - thyreostatikum - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - terlipressinum - poudre et solvant pour solution injectable - praeparatio cryodesiccata: terlipressini diacetas pentahydricus 1 mg corresp. terlipressinum 0.85 mg, mannitolum, acidum aceticum, pro vitro. solvens: natrii chloridum corresp. natrium 17.7 mg, aqua ad iniectabile ad solutionem pro 5 ml. - traitement blutender oesophagusvarizen - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - zonisamidum - capsules - zonisamidum 25 mg, cellulosum microcristallinum, oleum vegetabile hydrogenatum, natrii laurilsulfas, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.015 mg. - antiepileptikum - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - zonisamidum - capsules - zonisamidum 50 mg, cellulosum microcristallinum, oleum vegetabile hydrogenatum, natrii laurilsulfas, kapselhülle: gelatina, e 171, e 172 (nigrum), drucktinte: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.03 mg. - antiepileptikum - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - zonisamidum - capsules - zonisamidum 100 mg, cellulosum microcristallinum, oleum vegetabile hydrogenatum, natrii laurilsulfas, kapselhülle: gelatina, e 171, e 129 0.147 mg, e 110 0.002 mg, drucktinte: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.06 mg. - antiepileptikum - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - hydroxocobalaminum - lyophilisat pour solution pour perfusion - praeparatio cryodesiccata: hydroxocobalaminum 5 g, acidum hydrochloridum concentratum, pro vitro. - traitement connues ou présumées intoxication au cyanure - antidota

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - trientinum - comprimés pelliculés - trientinum 150 mg ut trientini tetrahydrochloridum, mannitolum, silica colloidalis anhydrica, glyceroli dibehenas, Überzug: poly(alcohol vinylicus), talcum, e 171, glyceroli monocaprylocapras, e 172 (flavum), natrii laurilsulfas corresp. natrium 0.057 mg, pro compresso obducto. - behandlung von morbus wilson bei bei erwachsenen, jugendlichen und kindern im alter von 5 jahren oder älter mit unverträglichkeit gegenüber einer d-penicillamin-therapie - synthetika

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - azacitidinum - poudre pour la fabrication d'une suspension injectable - azacitidinum 100 mg, mannitolum, pour le verre. - cytostatique - synthetika

Unione Europea - francese - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - imagerie des radionucléides - produits radiopharmaceutiques de diagnostic - ce médicament est destiné à un usage diagnostique uniquement. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Svizzera - francese - Swissmedic (Swiss Agency for Therapeutic Products)

curatis ag - etilefrini hydrochloridum - gouttes - etilefrini hydrochloridum 7,5 mg, antiox.: e 223, conserv.: propylis parahydroxybenzoas, e 218, excipiens à la solution pro 1 g corresp. 15 gouttes. - kreislaufanaleptikum, hypotonie - synthetika